Chun Sheng Li
Directeur/Bestuurslid bij Chongqing Genrix Biopharmaceutical Co., Ltd.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ji Kuan Shan | M | 52 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 jaar |
Yun Tong Hu | M | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 jaar |
Zhi Yuan Chang | M | 44 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 jaar |
Zhi Gang Liu | M | 51 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 4 jaar |
Li Wen Liu | M | 33 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 jaar |
Dong Zhi Wei | M | 61 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 jaar |
Li Chen | M | 47 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 jaar |
Ren Sheng Jiang | M | 71 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 jaar |
Jia Qian Yang | F | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 jaar |
Min Kou | F | 39 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 jaar |
Hong Fan | F | 36 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 jaar |
Jun Hua Qian | M | 57 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
China | 12 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Chun Sheng Li
- Persoonlijk netwerk